nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN3A—spinal nerve—multiple sclerosis	0.113	0.167	CbGeAlD
Phenazopyridine—SCN11A—peripheral nervous system—multiple sclerosis	0.0603	0.0892	CbGeAlD
Phenazopyridine—SCN11A—nerve—multiple sclerosis	0.047	0.0695	CbGeAlD
Phenazopyridine—SCN8A—peripheral nervous system—multiple sclerosis	0.0457	0.0676	CbGeAlD
Phenazopyridine—SCN8A—nerve—multiple sclerosis	0.0356	0.0527	CbGeAlD
Phenazopyridine—SCN10A—peripheral nervous system—multiple sclerosis	0.0306	0.0452	CbGeAlD
Phenazopyridine—SCN10A—nerve—multiple sclerosis	0.0238	0.0352	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—CD24—multiple sclerosis	0.0168	0.0591	CbGpPWpGaD
Phenazopyridine—SCN8A—brainstem—multiple sclerosis	0.0153	0.0226	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—CD24—multiple sclerosis	0.015	0.0527	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—CD24—multiple sclerosis	0.0137	0.0482	CbGpPWpGaD
Phenazopyridine—SCN11A—spinal cord—multiple sclerosis	0.0125	0.0186	CbGeAlD
Phenazopyridine—SCN1A—brainstem—multiple sclerosis	0.0116	0.0171	CbGeAlD
Phenazopyridine—SCN9A—L1CAM interactions—CD24—multiple sclerosis	0.0111	0.039	CbGpPWpGaD
Phenazopyridine—SCN2A—brainstem—multiple sclerosis	0.0106	0.0157	CbGeAlD
Phenazopyridine—SCN3A—L1CAM interactions—CD24—multiple sclerosis	0.0106	0.0373	CbGpPWpGaD
Phenazopyridine—SCN11A—nervous system—multiple sclerosis	0.0106	0.0156	CbGeAlD
Phenazopyridine—SCN4A—L1CAM interactions—CD24—multiple sclerosis	0.0102	0.0358	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—CD24—multiple sclerosis	0.0102	0.0358	CbGpPWpGaD
Phenazopyridine—SCN11A—central nervous system—multiple sclerosis	0.0102	0.0151	CbGeAlD
Phenazopyridine—SCN10A—L1CAM interactions—CD24—multiple sclerosis	0.00982	0.0345	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—CD24—multiple sclerosis	0.00982	0.0345	CbGpPWpGaD
Phenazopyridine—SCN8A—spinal cord—multiple sclerosis	0.00951	0.0141	CbGeAlD
Phenazopyridine—SCN9A—midbrain—multiple sclerosis	0.00857	0.0127	CbGeAlD
Phenazopyridine—SCN9A—spinal cord—multiple sclerosis	0.00836	0.0124	CbGeAlD
Phenazopyridine—SCN11A—brain—multiple sclerosis	0.00808	0.0119	CbGeAlD
Phenazopyridine—SCN1A—medulla oblongata—multiple sclerosis	0.00806	0.0119	CbGeAlD
Phenazopyridine—SCN8A—nervous system—multiple sclerosis	0.00801	0.0118	CbGeAlD
Phenazopyridine—SCN8A—central nervous system—multiple sclerosis	0.00771	0.0114	CbGeAlD
Phenazopyridine—SCN8A—cerebellum—multiple sclerosis	0.00754	0.0111	CbGeAlD
Phenazopyridine—SCN2A—medulla oblongata—multiple sclerosis	0.0074	0.0109	CbGeAlD
Phenazopyridine—SCN1A—midbrain—multiple sclerosis	0.00737	0.0109	CbGeAlD
Phenazopyridine—SCN1A—spinal cord—multiple sclerosis	0.00719	0.0106	CbGeAlD
Phenazopyridine—SCN5A—L1CAM interactions—CD24—multiple sclerosis	0.0069	0.0243	CbGpPWpGaD
Phenazopyridine—SCN7A—brain—multiple sclerosis	0.00687	0.0102	CbGeAlD
Phenazopyridine—SCN2A—midbrain—multiple sclerosis	0.00676	0.01	CbGeAlD
Phenazopyridine—SCN2A—spinal cord—multiple sclerosis	0.0066	0.00976	CbGeAlD
Phenazopyridine—SCN3A—medulla oblongata—multiple sclerosis	0.0065	0.00962	CbGeAlD
Phenazopyridine—SCN10A—spinal cord—multiple sclerosis	0.00636	0.00941	CbGeAlD
Phenazopyridine—SCN7A—Axon guidance—CD24—multiple sclerosis	0.00635	0.0223	CbGpPWpGaD
Phenazopyridine—SCN4A—nervous system—multiple sclerosis	0.00628	0.00929	CbGeAlD
Phenazopyridine—SCN8A—brain—multiple sclerosis	0.00612	0.00906	CbGeAlD
Phenazopyridine—SCN1A—nervous system—multiple sclerosis	0.00606	0.00896	CbGeAlD
Phenazopyridine—SCN4A—central nervous system—multiple sclerosis	0.00605	0.00894	CbGeAlD
Phenazopyridine—SCN3A—midbrain—multiple sclerosis	0.00594	0.00879	CbGeAlD
Phenazopyridine—SCN1A—central nervous system—multiple sclerosis	0.00583	0.00862	CbGeAlD
Phenazopyridine—SCN3A—spinal cord—multiple sclerosis	0.0058	0.00857	CbGeAlD
Phenazopyridine—SCN1A—cerebellum—multiple sclerosis	0.0057	0.00843	CbGeAlD
Phenazopyridine—SCN11A—Axon guidance—CD24—multiple sclerosis	0.00566	0.0199	CbGpPWpGaD
Phenazopyridine—SCN2A—nervous system—multiple sclerosis	0.00556	0.00822	CbGeAlD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00551	0.0194	CbGpPWpGaD
Phenazopyridine—SCN9A—brain—multiple sclerosis	0.00538	0.00796	CbGeAlD
Phenazopyridine—SCN10A—nervous system—multiple sclerosis	0.00536	0.00793	CbGeAlD
Phenazopyridine—SCN2A—central nervous system—multiple sclerosis	0.00535	0.00791	CbGeAlD
Phenazopyridine—SCN2A—cerebellum—multiple sclerosis	0.00523	0.00774	CbGeAlD
Phenazopyridine—SCN8A—Axon guidance—CD24—multiple sclerosis	0.00518	0.0182	CbGpPWpGaD
Phenazopyridine—SCN10A—central nervous system—multiple sclerosis	0.00516	0.00763	CbGeAlD
Phenazopyridine—SCN3A—nervous system—multiple sclerosis	0.00489	0.00722	CbGeAlD
Phenazopyridine—SCN5A—nervous system—multiple sclerosis	0.00487	0.0072	CbGeAlD
Phenazopyridine—SCN4A—brain—multiple sclerosis	0.0048	0.0071	CbGeAlD
Phenazopyridine—SCN3A—central nervous system—multiple sclerosis	0.0047	0.00696	CbGeAlD
Phenazopyridine—SCN5A—central nervous system—multiple sclerosis	0.00469	0.00694	CbGeAlD
Phenazopyridine—SCN1A—brain—multiple sclerosis	0.00463	0.00685	CbGeAlD
Phenazopyridine—SCN3A—cerebellum—multiple sclerosis	0.0046	0.0068	CbGeAlD
Phenazopyridine—SCN7A—Developmental Biology—CD24—multiple sclerosis	0.00453	0.0159	CbGpPWpGaD
Phenazopyridine—SCN2A—brain—multiple sclerosis	0.00425	0.00628	CbGeAlD
Phenazopyridine—SCN9A—Axon guidance—CD24—multiple sclerosis	0.00419	0.0147	CbGpPWpGaD
Phenazopyridine—SCN10A—brain—multiple sclerosis	0.0041	0.00606	CbGeAlD
Phenazopyridine—SCN11A—Developmental Biology—CD24—multiple sclerosis	0.00404	0.0142	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—CD24—multiple sclerosis	0.00401	0.0141	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—CD24—multiple sclerosis	0.00385	0.0135	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—CD24—multiple sclerosis	0.00385	0.0135	CbGpPWpGaD
Phenazopyridine—SCN3A—brain—multiple sclerosis	0.00373	0.00552	CbGeAlD
Phenazopyridine—SCN5A—brain—multiple sclerosis	0.00372	0.00551	CbGeAlD
Phenazopyridine—SCN10A—Axon guidance—CD24—multiple sclerosis	0.00371	0.013	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—CD24—multiple sclerosis	0.00371	0.013	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CD24—multiple sclerosis	0.0037	0.013	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CD24—multiple sclerosis	0.00299	0.0105	CbGpPWpGaD
Phenazopyridine—Meningitis aseptic—Methotrexate—multiple sclerosis	0.00292	0.0744	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—CD24—multiple sclerosis	0.00286	0.0101	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CD24—multiple sclerosis	0.00275	0.00966	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CD24—multiple sclerosis	0.00275	0.00966	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CD24—multiple sclerosis	0.00265	0.00931	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CD24—multiple sclerosis	0.00265	0.00931	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—CD24—multiple sclerosis	0.00261	0.00917	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00229	0.00804	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—PRNP—multiple sclerosis	0.0021	0.00737	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—PRNP—multiple sclerosis	0.00187	0.00657	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.00186	0.00655	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00173	0.00609	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—PRNP—multiple sclerosis	0.00171	0.00601	CbGpPWpGaD
Phenazopyridine—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00169	0.0431	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—PTPRC—multiple sclerosis	0.00163	0.00573	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PRNP—multiple sclerosis	0.0015	0.00526	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—PTPRC—multiple sclerosis	0.00145	0.00511	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—PRNP—multiple sclerosis	0.00138	0.00486	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PRNP—multiple sclerosis	0.00133	0.00469	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—PTPRC—multiple sclerosis	0.00133	0.00467	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—PRNP—multiple sclerosis	0.00132	0.00465	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—PRNP—multiple sclerosis	0.00127	0.00446	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—PRNP—multiple sclerosis	0.00127	0.00446	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—MAPK1—multiple sclerosis	0.00123	0.00432	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—PRNP—multiple sclerosis	0.00122	0.0043	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—PRNP—multiple sclerosis	0.00122	0.0043	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PRNP—multiple sclerosis	0.00122	0.00429	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PTPRC—multiple sclerosis	0.00116	0.00409	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00114	0.0291	CcSEcCtD
Phenazopyridine—SCN11A—L1CAM interactions—MAPK1—multiple sclerosis	0.00109	0.00385	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—PTPRC—multiple sclerosis	0.00107	0.00378	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PTPRC—multiple sclerosis	0.00104	0.00364	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—PTPRC—multiple sclerosis	0.00103	0.00361	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—MAPK1—multiple sclerosis	0.001	0.00352	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—PTPRC—multiple sclerosis	0.000987	0.00347	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—PTPRC—multiple sclerosis	0.000987	0.00347	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PRNP—multiple sclerosis	0.000986	0.00347	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—PTPRC—multiple sclerosis	0.000952	0.00335	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—PTPRC—multiple sclerosis	0.000952	0.00335	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PTPRC—multiple sclerosis	0.000948	0.00333	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PRNP—multiple sclerosis	0.000943	0.00332	CbGpPWpGaD
Phenazopyridine—Pruritus—Fingolimod—multiple sclerosis	0.000936	0.0238	CcSEcCtD
Phenazopyridine—SCN4A—Developmental Biology—PRNP—multiple sclerosis	0.000906	0.00319	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PRNP—multiple sclerosis	0.000906	0.00319	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Fingolimod—multiple sclerosis	0.000905	0.0231	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000896	0.00315	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PRNP—multiple sclerosis	0.000874	0.00307	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PRNP—multiple sclerosis	0.000874	0.00307	CbGpPWpGaD
Phenazopyridine—Visual disturbance—Prednisolone—multiple sclerosis	0.000868	0.0221	CcSEcCtD
Phenazopyridine—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000861	0.00303	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000856	0.00301	CbGpPWpGaD
Phenazopyridine—Headache—Fingolimod—multiple sclerosis	0.000829	0.0211	CcSEcCtD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000827	0.00291	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—MAPK1—multiple sclerosis	0.00081	0.00285	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—MAPK1—multiple sclerosis	0.000775	0.00272	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PTPRC—multiple sclerosis	0.000767	0.0027	CbGpPWpGaD
Phenazopyridine—Jaundice—Mitoxantrone—multiple sclerosis	0.000753	0.0192	CcSEcCtD
Phenazopyridine—SCN4A—L1CAM interactions—MAPK1—multiple sclerosis	0.000744	0.00262	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—MAPK1—multiple sclerosis	0.000744	0.00262	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PTPRC—multiple sclerosis	0.000733	0.00258	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—TYK2—multiple sclerosis	0.000729	0.00256	CbGpPWpGaD
Phenazopyridine—Visual disturbance—Dexamethasone—multiple sclerosis	0.000725	0.0185	CcSEcCtD
Phenazopyridine—Visual disturbance—Betamethasone—multiple sclerosis	0.000725	0.0185	CcSEcCtD
Phenazopyridine—SCN1A—L1CAM interactions—MAPK1—multiple sclerosis	0.000718	0.00252	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—MAPK1—multiple sclerosis	0.000718	0.00252	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PTPRC—multiple sclerosis	0.000705	0.00248	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PTPRC—multiple sclerosis	0.000705	0.00248	CbGpPWpGaD
Phenazopyridine—Hepatitis—Mitoxantrone—multiple sclerosis	0.000694	0.0177	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—PTPRC—multiple sclerosis	0.000679	0.00239	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PTPRC—multiple sclerosis	0.000679	0.00239	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000669	0.00235	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—TYK2—multiple sclerosis	0.00065	0.00229	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000647	0.0165	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.000614	0.00216	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—TYK2—multiple sclerosis	0.000594	0.00209	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—MMP9—multiple sclerosis	0.000574	0.00202	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Cladribine—multiple sclerosis	0.000553	0.0141	CcSEcCtD
Phenazopyridine—Visual impairment—Prednisolone—multiple sclerosis	0.000549	0.014	CcSEcCtD
Phenazopyridine—Pruritus—Cladribine—multiple sclerosis	0.000531	0.0135	CcSEcCtD
Phenazopyridine—Visual disturbance—Methotrexate—multiple sclerosis	0.000527	0.0134	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000526	0.0134	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—TYK2—multiple sclerosis	0.00052	0.00183	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Cladribine—multiple sclerosis	0.000513	0.0131	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—MMP9—multiple sclerosis	0.000512	0.0018	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000504	0.00177	CbGpPWpGaD
Phenazopyridine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000503	0.0128	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—TYK2—multiple sclerosis	0.000481	0.00169	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.000478	0.00168	CbGpPWpGaD
Phenazopyridine—Vomiting—Cladribine—multiple sclerosis	0.000477	0.0121	CcSEcCtD
Phenazopyridine—Rash—Cladribine—multiple sclerosis	0.000473	0.012	CcSEcCtD
Phenazopyridine—Dermatitis—Cladribine—multiple sclerosis	0.000472	0.012	CcSEcCtD
Phenazopyridine—Headache—Cladribine—multiple sclerosis	0.00047	0.012	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—MMP9—multiple sclerosis	0.000468	0.00165	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—MAPK1—multiple sclerosis	0.000464	0.00163	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TYK2—multiple sclerosis	0.000464	0.00163	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—TYK2—multiple sclerosis	0.00046	0.00162	CbGpPWpGaD
Phenazopyridine—Visual impairment—Dexamethasone—multiple sclerosis	0.000458	0.0117	CcSEcCtD
Phenazopyridine—Visual impairment—Betamethasone—multiple sclerosis	0.000458	0.0117	CcSEcCtD
Phenazopyridine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000449	0.0114	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000449	0.00158	CbGpPWpGaD
Phenazopyridine—Nausea—Cladribine—multiple sclerosis	0.000445	0.0114	CcSEcCtD
Phenazopyridine—SCN2A—Axon guidance—TYK2—multiple sclerosis	0.000442	0.00155	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—TYK2—multiple sclerosis	0.000442	0.00155	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000434	0.0111	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—TYK2—multiple sclerosis	0.000426	0.0015	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—TYK2—multiple sclerosis	0.000426	0.0015	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TYK2—multiple sclerosis	0.000424	0.00149	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Azathioprine—multiple sclerosis	0.000417	0.0106	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—MAPK1—multiple sclerosis	0.000414	0.00145	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MMP9—multiple sclerosis	0.00041	0.00144	CbGpPWpGaD
Phenazopyridine—Vomiting—Azathioprine—multiple sclerosis	0.000388	0.00988	CcSEcCtD
Phenazopyridine—Rash—Azathioprine—multiple sclerosis	0.000384	0.0098	CcSEcCtD
Phenazopyridine—Dermatitis—Azathioprine—multiple sclerosis	0.000384	0.00979	CcSEcCtD
Phenazopyridine—Headache—Azathioprine—multiple sclerosis	0.000382	0.00973	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—MMP9—multiple sclerosis	0.000379	0.00133	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MAPK1—multiple sclerosis	0.000378	0.00133	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—multiple sclerosis	0.000365	0.00128	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—STAT3—multiple sclerosis	0.000364	0.00128	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000363	0.00925	CcSEcCtD
Phenazopyridine—Nausea—Azathioprine—multiple sclerosis	0.000362	0.00923	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—MMP9—multiple sclerosis	0.000362	0.00127	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—multiple sclerosis	0.000357	0.00125	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—multiple sclerosis	0.000348	0.00122	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—multiple sclerosis	0.000348	0.00122	CbGpPWpGaD
Phenazopyridine—Hepatitis—Methotrexate—multiple sclerosis	0.000346	0.00881	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—TYK2—multiple sclerosis	0.000343	0.00121	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—multiple sclerosis	0.000338	0.00119	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000337	0.00859	CcSEcCtD
Phenazopyridine—SCN1A—Axon guidance—MMP9—multiple sclerosis	0.000335	0.00118	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—multiple sclerosis	0.000335	0.00118	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—multiple sclerosis	0.000334	0.00117	CbGpPWpGaD
Phenazopyridine—Visual impairment—Methotrexate—multiple sclerosis	0.000333	0.00849	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—MAPK1—multiple sclerosis	0.000331	0.00116	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TYK2—multiple sclerosis	0.000328	0.00115	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000327	0.00834	CcSEcCtD
Phenazopyridine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000327	0.00832	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000326	0.00115	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—STAT3—multiple sclerosis	0.000325	0.00114	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—multiple sclerosis	0.000318	0.00112	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—multiple sclerosis	0.000315	0.00111	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	0.000315	0.00111	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TYK2—multiple sclerosis	0.000315	0.00111	CbGpPWpGaD
Phenazopyridine—Vomiting—Mitoxantrone—multiple sclerosis	0.000313	0.00799	CcSEcCtD
Phenazopyridine—Rash—Mitoxantrone—multiple sclerosis	0.000311	0.00792	CcSEcCtD
Phenazopyridine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000311	0.00791	CcSEcCtD
Phenazopyridine—Headache—Mitoxantrone—multiple sclerosis	0.000309	0.00787	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—MAPK1—multiple sclerosis	0.000306	0.00108	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TYK2—multiple sclerosis	0.000304	0.00107	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TYK2—multiple sclerosis	0.000304	0.00107	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—multiple sclerosis	0.000301	0.00106	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—TYK2—multiple sclerosis	0.000299	0.00105	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000298	0.00759	CcSEcCtD
Phenazopyridine—Dyspepsia—Betamethasone—multiple sclerosis	0.000297	0.00757	CcSEcCtD
Phenazopyridine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000297	0.00757	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—STAT3—multiple sclerosis	0.000297	0.00104	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MAPK1—multiple sclerosis	0.000295	0.00104	CbGpPWpGaD
Phenazopyridine—Nausea—Mitoxantrone—multiple sclerosis	0.000293	0.00746	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—MAPK1—multiple sclerosis	0.000293	0.00103	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000291	0.00742	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000291	0.00742	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—IL6—multiple sclerosis	0.000291	0.00102	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	0.000281	0.000989	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MAPK1—multiple sclerosis	0.000281	0.000989	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—multiple sclerosis	0.000281	0.000988	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—multiple sclerosis	0.000275	0.000968	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000274	0.00698	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000273	0.00697	CcSEcCtD
Phenazopyridine—SCN1A—Axon guidance—MAPK1—multiple sclerosis	0.000271	0.000953	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	0.000271	0.000953	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	0.00027	0.00095	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MAPK1—multiple sclerosis	0.00027	0.000949	CbGpPWpGaD
Phenazopyridine—Pruritus—Triamcinolone—multiple sclerosis	0.000263	0.0067	CcSEcCtD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000263	0.000924	CbGpPWpGaD
Phenazopyridine—Pruritus—Methylprednisolone—multiple sclerosis	0.000263	0.00669	CcSEcCtD
Phenazopyridine—Dyspepsia—Prednisone—multiple sclerosis	0.000259	0.00659	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—multiple sclerosis	0.000258	0.000909	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—multiple sclerosis	0.000257	0.000904	CbGpPWpGaD
Phenazopyridine—Rash—Prednisolone—multiple sclerosis	0.000255	0.0065	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisolone—multiple sclerosis	0.000255	0.00649	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—IL6—multiple sclerosis	0.000254	0.000895	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000254	0.00647	CcSEcCtD
Phenazopyridine—Headache—Prednisolone—multiple sclerosis	0.000253	0.00646	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—multiple sclerosis	0.000248	0.000873	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	0.000248	0.000873	CbGpPWpGaD
Phenazopyridine—Nausea—Prednisolone—multiple sclerosis	0.00024	0.00612	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	0.00024	0.000845	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	0.000239	0.000842	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—multiple sclerosis	0.000239	0.000842	CbGpPWpGaD
Phenazopyridine—Pruritus—Dexamethasone—multiple sclerosis	0.000239	0.00608	CcSEcCtD
Phenazopyridine—Pruritus—Betamethasone—multiple sclerosis	0.000239	0.00608	CcSEcCtD
Phenazopyridine—Vomiting—Triamcinolone—multiple sclerosis	0.000236	0.00603	CcSEcCtD
Phenazopyridine—Vomiting—Methylprednisolone—multiple sclerosis	0.000236	0.00601	CcSEcCtD
Phenazopyridine—SCN5A—Axon guidance—MMP9—multiple sclerosis	0.000236	0.000829	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—multiple sclerosis	0.000235	0.000827	CbGpPWpGaD
Phenazopyridine—Rash—Triamcinolone—multiple sclerosis	0.000235	0.00597	CcSEcCtD
Phenazopyridine—Dermatitis—Triamcinolone—multiple sclerosis	0.000234	0.00597	CcSEcCtD
Phenazopyridine—Rash—Methylprednisolone—multiple sclerosis	0.000234	0.00596	CcSEcCtD
Phenazopyridine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000234	0.00596	CcSEcCtD
Phenazopyridine—Headache—Triamcinolone—multiple sclerosis	0.000233	0.00594	CcSEcCtD
Phenazopyridine—Headache—Methylprednisolone—multiple sclerosis	0.000232	0.00592	CcSEcCtD
Phenazopyridine—Diarrhoea—Betamethasone—multiple sclerosis	0.000231	0.00588	CcSEcCtD
Phenazopyridine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000231	0.00588	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—STAT3—multiple sclerosis	0.00023	0.000808	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—multiple sclerosis	0.000227	0.000798	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—multiple sclerosis	0.000225	0.000791	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	0.000223	0.000783	CbGpPWpGaD
Phenazopyridine—Nausea—Triamcinolone—multiple sclerosis	0.000221	0.00563	CcSEcCtD
Phenazopyridine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	0.000221	0.000776	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—STAT3—multiple sclerosis	0.000221	0.000776	CbGpPWpGaD
Phenazopyridine—Nausea—Methylprednisolone—multiple sclerosis	0.00022	0.00562	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	0.000218	0.000768	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Prednisone—multiple sclerosis	0.000217	0.00552	CcSEcCtD
Phenazopyridine—Dyspepsia—Methotrexate—multiple sclerosis	0.000216	0.00551	CcSEcCtD
Phenazopyridine—SCN2A—Axon guidance—IL6—multiple sclerosis	0.000216	0.00076	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—multiple sclerosis	0.000216	0.00076	CbGpPWpGaD
Phenazopyridine—Vomiting—Betamethasone—multiple sclerosis	0.000215	0.00547	CcSEcCtD
Phenazopyridine—Vomiting—Dexamethasone—multiple sclerosis	0.000215	0.00547	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	0.000214	0.000751	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	0.000213	0.000749	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	0.000213	0.000748	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—STAT3—multiple sclerosis	0.000213	0.000748	CbGpPWpGaD
Phenazopyridine—Rash—Dexamethasone—multiple sclerosis	0.000213	0.00542	CcSEcCtD
Phenazopyridine—Rash—Betamethasone—multiple sclerosis	0.000213	0.00542	CcSEcCtD
Phenazopyridine—Dermatitis—Dexamethasone—multiple sclerosis	0.000213	0.00542	CcSEcCtD
Phenazopyridine—Dermatitis—Betamethasone—multiple sclerosis	0.000213	0.00542	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000212	0.0054	CcSEcCtD
Phenazopyridine—Headache—Dexamethasone—multiple sclerosis	0.000211	0.00539	CcSEcCtD
Phenazopyridine—Headache—Betamethasone—multiple sclerosis	0.000211	0.00539	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	0.000209	0.000734	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—multiple sclerosis	0.000208	0.000733	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—multiple sclerosis	0.000208	0.000733	CbGpPWpGaD
Phenazopyridine—Pruritus—Prednisone—multiple sclerosis	0.000208	0.0053	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—TNF—multiple sclerosis	0.000208	0.000731	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—multiple sclerosis	0.000207	0.000729	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	0.000205	0.000719	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	0.000205	0.000719	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Prednisone—multiple sclerosis	0.000201	0.00512	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	0.000201	0.000706	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	0.000201	0.000706	CbGpPWpGaD
Phenazopyridine—Nausea—Dexamethasone—multiple sclerosis	0.0002	0.00511	CcSEcCtD
Phenazopyridine—Nausea—Betamethasone—multiple sclerosis	0.0002	0.00511	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—TNF—multiple sclerosis	0.000199	0.000699	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	0.000197	0.000694	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	0.000197	0.000694	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	0.000193	0.00068	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	0.000193	0.00068	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—multiple sclerosis	0.000191	0.000672	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—multiple sclerosis	0.000191	0.000672	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	0.000191	0.00067	CbGpPWpGaD
Phenazopyridine—Vomiting—Prednisone—multiple sclerosis	0.000187	0.00476	CcSEcCtD
Phenazopyridine—Rash—Prednisone—multiple sclerosis	0.000185	0.00472	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisone—multiple sclerosis	0.000185	0.00472	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—TNF—multiple sclerosis	0.000184	0.000648	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—multiple sclerosis	0.000184	0.000648	CbGpPWpGaD
Phenazopyridine—Headache—Prednisone—multiple sclerosis	0.000184	0.00469	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000181	0.00461	CcSEcCtD
Phenazopyridine—Nausea—Prednisone—multiple sclerosis	0.000175	0.00445	CcSEcCtD
Phenazopyridine—Pruritus—Methotrexate—multiple sclerosis	0.000174	0.00443	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	0.000168	0.000592	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Methotrexate—multiple sclerosis	0.000168	0.00428	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—IL6—multiple sclerosis	0.000168	0.00059	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—multiple sclerosis	0.00016	0.000564	CbGpPWpGaD
Phenazopyridine—Vomiting—Methotrexate—multiple sclerosis	0.000156	0.00398	CcSEcCtD
Phenazopyridine—Rash—Methotrexate—multiple sclerosis	0.000155	0.00395	CcSEcCtD
Phenazopyridine—Dermatitis—Methotrexate—multiple sclerosis	0.000155	0.00394	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—IL6—multiple sclerosis	0.000154	0.000542	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—multiple sclerosis	0.000154	0.000542	CbGpPWpGaD
Phenazopyridine—Headache—Methotrexate—multiple sclerosis	0.000154	0.00392	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	0.00015	0.000526	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—multiple sclerosis	0.000149	0.000523	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—multiple sclerosis	0.000149	0.000523	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—multiple sclerosis	0.000146	0.000515	CbGpPWpGaD
Phenazopyridine—Nausea—Methotrexate—multiple sclerosis	0.000146	0.00372	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	0.000139	0.000488	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	0.000136	0.000478	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—multiple sclerosis	0.00013	0.000455	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—multiple sclerosis	0.000105	0.000368	CbGpPWpGaD
